Uncategorized

Investor’s Watch List: Liberty Media Corporation (NASDAQ:FWONK) & NovoCure Limited (NASDAQ:NVCR)

Liberty Media Corporation (NASDAQ:FWONK)

Liberty Media Corporation owns interests in a broad range of media, communications and entertainment businesses through their operating subsidiaries and investments in various publicly-traded companies. The company broadcasts music, sports, entertainment, comedy, talk, news, traffic, and weather channels, as well as infotainment services on a subscription fee basis through its satellite radio systems; provides next-generation connected vehicle applications and services; streams music and non-music channels over the Internet; sells satellite and Internet radios to consumers through Website and retailers; and offers other ancillary services, such as weather, traffic, data, and Backseat television services. Liberty Media Corporation is headquartered in Englewood, Colorado.

Liberty Media Corporation (NASDAQ:FWONK)’s Financial Overview

Liberty Media Corporation (NASDAQ) surged 2.62% yesterday to close its trading session at $31.32. The company has 1 year Price Target of $40.75. Liberty Media Corporation has 52-Week high of $39.35 and 52-Week Low of $27.51. The stock touched its 52-Week High on 39.35 and 52-Week Low on 27.51. The stock traded with the volume of 1.22 Million shares yesterday. The firm shows the market capitalization of $6.35 Billion.

Liberty Media Corporation (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.18/share against the analyst consensus estimate of $0.11/share. The difference between the actual and expected EPS is $0.07 a share with a surprise factor of 63.6%.

The firm is trading with SMA20 of 0.26 Percent, SMA50 of 1.12 Percent and SMA200 of -6.31 percent. Liberty Media Corporation has P/S value of 3.32 while its P/B value stands at 1.27. Similarly, the company has Return on Assets of 0 percent, Return on Equity of 0 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 2.2 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 9 analysts offering 12-month price forecasts for Liberty Media Corp have a median target of 40.00, with a high estimate of 49.00 and a low estimate of 34.00. The median estimate represents a +27.71% increase from the last price of 31.32.

Liberty Media Corporation is expected* to report earnings on 02/28/2019 before market open. The report will be for the fiscal Quarter ending Dec 2018. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.42. The reported EPS for the same quarter last year was $1.79.

NovoCure Limited (NASDAQ:NVCR)

NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.

NovoCure Limited (NASDAQ:NVCR)’s Financial Outlook

The 5 analysts offering 12-month price forecasts for Novocure Ltd have a median target of 44.00, with a high estimate of 55.00 and a low estimate of 36.00. The median estimate represents a -14.18% decrease from the last price of 51.27.

NovoCure Limited is expected* to report earnings on 02/28/2019 before market open. The report will be for the fiscal Quarter ending Dec 2018. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.16. The reported EPS for the same quarter last year was $-0.12.

According to Zacks Investment Research, NovoCure Limited has a Consensus Recommendation of 1.5. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock surged 1.61% and closed its last trading session at $51.27. The company has the market capitalization of $4.77 Billion. The stock has 52-week high of $53.7 and 52-Week low of $19.2. The firm touched its 52-Week high on 53.70 and 52-Week low on 19.20. The company has volume of 563012 shares. The company has a total of 92.98 Million shares outstanding.

NovoCure Limited (NASDAQ) in the last quarter reported its actual EPS of $-0.13/share where the analyst estimated EPS was $-0.15/share. The difference between the actual and Estimated EPS is $0.02. This shows a surprise factor of 13.3 percent.

The company has YTD performance of 53.14 percent. Beta for NovoCure Limited stands at 3.25 while its ATR (average true range) is 1.67. The company has Weekly Volatility of 2.67%% and Monthly Volatility of 3.24%%.

NovoCure Limited has distance from 20-day Simple Moving Average (SMA20) of 7.11%, Distance from 50-Day Simple Moving Average of 28.72 percent and Distance from 200-Day Simple Moving Average of 37.71%.

The Company currently has ROA (Return on Assets) of -19.7 percent, Return on Equity (ROE) of -52.7 Percent and Return on Investment (ROI) of -41.4% with Gross margin of 68.7 percent and Operating & Profit margin of -12.7% and -25.4% respectively.